Skip to content

Comparison effectiveness of acceptance and commitment therapy (ACT) and drug therapy on depression

Comparison effectiveness of acceptance and commitment therapy (ACT) and drug therapy on improving patients with major depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017070334862N1
Enrollment
45
Registered
2017-07-19
Start date
2015-03-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder. Severe depressive episode without psychotic symptoms

Interventions

Intervention 1: Acceptance and Commitment Group Therapy: In this research, the Acceptance and Commitment-based Treatment Group (ACT) is an 8-session intervention program (90 minutes each week), in whi
Treatment - Other
Treatment - Drugs
The control group did not receive any kind of treatment, but the control group was told that after the research they could attend admissions and admission treatment sessions.
Acceptance and Commitment Group Therapy: In this research, the Acceptance and Commitment-based Treatment Group (ACT) is an 8-session intervention program (90 minutes each week), in which the members o
Medication Constant dose intake of antidepressants including triple tyline (alivyl), trimimipramine (surmontelium) and alprazolam was monitored and administered by a psychiatrist by psychiatric and p

Sponsors

Deputy of Research of Bandar Abbas Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Aims: The aim of this study was to compare the efficacy of group therapy based on admission and commitment and drug therapy on the improvement of patients with major depression. (2) Design: The research design was semi-experimental and pre-test-posttest with two experimental groups and one control group. (3) How to do it (3) Setting and conduct (4) Participants: The statistical population of the study included all patients with major depressive disorder in Shahrekord's well-being care centers in 1994. The study sample consisted of 45 patients who were selected by convenience sampling and randomly assigned to two experimental groups with acceptance and commitment and drug therapy and one control group. Beck Depression Scale (BDI) and Coopersmith's Self-Esteem Questionnaire were used for data collection in pre-test and post-test. Data were analyzed by analysis of univariate covariance and Scheffe post hoc test and SPSS software. (5) interventions: group therapy based on acceptance and commitment and medication (6) Main outcome variables: Signs of major depression, self-esteem

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Symptoms of depression. Timepoint: Pre-test and post-test intervals of one month. Method of measurement: The Beck Depression Scale (BDI) was used to collect data. Data were analyzed by analysis of univariate covariance and Scheffe post hoc test and SPSS software.

Secondary

MeasureTime frame
Self-esteem. Timepoint: Pre-test and post-test intervals of one month. Method of measurement: The score is the score that the subjects earned in the Cooper Smith self-esteem questionnaire. Data were analyzed by analyzing univariate covariance and Scheffe post hoc test and SPSS software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasoul Alipour

Bandar Abbas Azad University

rasul69.a@gmail.com+98 913 721 0585

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026